Immix Biopharma, Inc.
IMMX
$8.18
$0.172.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 467.86% | -19.01% | -51.46% | -45.70% | 0.98% |
| Total Receivables | -- | -- | -- | -- | 68.44% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 33.07% | -52.12% | -56.70% | -50.60% | -52.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 366.56% | 263.84% | 30.15% | -3.88% | -27.58% |
| Total Current Assets | 401.23% | -27.12% | -54.90% | -49.02% | 2.07% |
|
|
|||||
| Total Current Assets | 401.23% | -27.12% | -54.90% | -49.02% | 2.07% |
| Net Property, Plant & Equipment | 27.80% | 42.21% | 114.09% | 119.02% | 5,337.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 458.82% | 547.55% | 542.16% | 0.00% | -76.61% |
| Total Assets | 356.86% | -20.13% | -45.78% | -42.09% | 15.17% |
|
|
|||||
| Total Accounts Payable | 1.01% | 114.39% | 181.87% | 63.45% | 276.03% |
| Total Accrued Expenses | 40.05% | 13.87% | 120.65% | 65.79% | 41.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 113.65% | 125.36% | 45.66% | 97.67% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.39% | 65.29% | 156.53% | 64.53% | 133.41% |
|
|
|||||
| Total Current Liabilities | 16.39% | 65.29% | 156.53% | 64.53% | 133.41% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.53% | -5.96% | -6.76% | -6.40% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.90% | 55.66% | 122.10% | 53.35% | 160.54% |
|
|
|||||
| Common Stock & APIC | 124.38% | 16.43% | 4.53% | 3.06% | 26.65% |
| Retained Earnings | -39.24% | -33.56% | -36.67% | -35.62% | -40.47% |
| Treasury Stock & Other | 60.59% | -140.72% | -305.29% | -720.39% | -391.07% |
| Total Common Equity | 607.83% | -52.91% | -80.52% | -65.63% | -19.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 607.83% | -52.91% | -80.52% | -65.63% | -19.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 607.83% | -52.91% | -80.52% | -65.28% | -18.22% |
|
|
|||||